Medical Malpractice related to nosocomial MRSA infections, comment


After reading the 1/16/2007 post regarding nosocomial infections especially with MRSA, I had to respond. I think hospitals all over the US need to adopt what the hospitals are already doing in Europe. The nose swabs are a fast and effective way of determining whether a pt is at risk or not for MRSA. Many pts prior to leaving the hospital setting, suffered from MRSA which became very demanding for the nurse and ancillary staff to care for. Pts were placed on isolation and had to go into the room completely gowned up which requires extra steps to an already busy schedule for a 8-12 hour shift. This testing would also maintain the reimbursement Medicare gives hospitals because as of October 2008, it was determined by COHIaBA, who governs Medicare stipulations, would be taking away money from the hospitals if pts were diagnosed with MRSA or greater than Stage 3 Pressure Ulcers. THis would mean a greater reimbursement which would help maintain staffing and salaries to nurses and other ancillary staff. I think this is a great idea to assist with the on going changes with health care that this country is going through right now.

Original Post
January 16, 2007
Title: Medical Malpractice related to nosocomial MRSA infections
The media and government have educated the public in the “super bugs” some patients become infected with in the hospital environment. The most widely known “super bug” is methicillin resistant staphylococcus aureus (MRSA). In June 2006 there was a case brought to court regarding the death of patient who had been in the hospital for a knee joint replacement. Since the patient had not been screened for MRSA prior to hospitalization it could not be proved if he picked up the MRSA during the hospital stay. With the documented community acquired MRSA he could have had the bacteria dormant in his body when he was admitted for the planned surgery. The doctor and hospital were not found negligent in this case.

Many hospitals are fearful of similar lawsuits based on nosocomial infections. Some hospitals are now culturing high-risk patients prior to hospital admission to determine if they are colonized. There is now a nasal swab test that has a turn around time of two hours to identify MRSA. Certainly this can be helpful so that colonized patients coming in for elective procedures can have this treated and also be isolated from non-colonized patients. Patients that test positive for MRSA can be cohorted with like patients or put in private rooms. There are multiple hospitals in Europe starting to follow this intervention with positive outcomes in their nosocomial rates.

It would seem to me the hospital administrators would prefer paying for the MRSA culture versus facing the potential of law suits from patients who develop nosocomial MRSA infections while inpatient. If I had a family member going to the hospital I would much prefer they be tested for MRSA prior to a surgery as “knowledge is power” Having the knowledge of colonized MRSA prior to surgical intervention can allow for adjustments that lead to positive outcomes for the hospital, surgeon and patient. I can visualize hospitals even being forced to do it to allow them better leverage in the court system by being able to say, “this person was colonized with MRSA” prior to hospital admission. From the epidemiology stand point it would also allow the opportunity to keep the more virulent strain of community MRSA from entering the hospital environment.

Healthcare Medical Malpractice Defense Attorney Lawyer

Online Forensic Nursing Course

Online Forensic Nursing Certificate Program

Tags: , , , , , , , ,

One Response to “Medical Malpractice related to nosocomial MRSA infections, comment”

  1. Moncler Says:

    It was an excellent post, thanks for the data.

Comments are closed.

%d bloggers like this: